Summary & Overview
CPT 93581: Transcatheter Ventricular Septal Defect Closure
CPT code 93581 denotes a percutaneous transcatheter ventricular septal defect (VSD) closure procedure, used to close a congenital opening between the heart’s lower chambers. The procedure involves venous catheter access (typically via the groin), contrast imaging of cardiac chambers, and placement of an implant to seal the septal defect. This code is central to reporting minimally invasive interventional cardiology management of selected congenital VSDs and carries implications for procedural authorization, hospital resource use, and device reimbursement nationally.
Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find clinical context for when transcatheter VSD closure is performed, typical sites of service, and payer coverage considerations. The publication provides benchmarks for utilization and payment trends, summaries of relevant policy updates affecting interventional congenital heart procedures, and comparisons of reimbursement patterns across major national payers. It also outlines common billing and documentation points relevant to hospital and physician claims submission for this interventional cardiac service.
Data not available in the input: Associated taxonomies, specific ICD-10 diagnoses, related codes, and payer-specific reimbursement rates.
Billing Code Overview
CPT code 93581 describes a transcatheter procedure to close a ventricular septal defect (VSD), an opening between the heart's lower chambers present from birth. The provider advances a catheter through a large vein in the groin into the right side of the heart, injects contrast to image the cardiac chambers, and deploys an implant to seal the septal opening.
-
Service type: Percutaneous transcatheter ventricular septal defect closure
-
Typical site of service: Inpatient or outpatient cardiac catheterization laboratory at a hospital or specialized cardiac center
Clinical & Coding Specifications
Clinical Context
A 6-year-old child with a clinically significant ventricular septal defect (VSD) presents with exertional dyspnea, recurrent respiratory infections, and evidence of left ventricular volume overload on echocardiography. The cardiology team schedules a transcatheter device closure. In the catheterization laboratory, under general anesthesia or conscious sedation depending on patient age and comorbidities, vascular access is obtained (commonly femoral vein). A sheath and diagnostic catheters are threaded to the right heart; contrast angiography is performed to define the size and location of the septal defect and to evaluate pulmonary pressures and chamber sizes. Based on measurements, an occlusion device is selected and delivered via a delivery catheter and sheath across the defect. The device is deployed and position is confirmed with angiography and echocardiography (transesophageal or intracardiac), then released. Hemostasis is achieved at access sites and the patient is monitored in recovery and for possible complications such as arrhythmia, device embolization, residual shunt, vascular injury, or access site bleeding. The clinical workflow includes pre-procedure imaging and labs, informed consent, intra-procedure imaging guidance, device implantation, post-procedure monitoring, and follow-up echocardiography to confirm closure and evaluate cardiac function.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier - standard coding | Use when no specific modifier applies and the service is reported as usual. |